首页 > 实验室动态 > 正文
发布日期:2016年06月16日    浏览次数:
学术报告:Dr. XiuJun (James) Li(2016年6月21日)


Hybrid microfluidic Lab-on-a-Chip and nanotechnologies for low-cost disease diagnosis


Dr. XiuJun (James) Li
Assistant Professor in the Department of Chemistry, University of Texas at El Paso, USA


时间:2016年6月21日(星期二)10:00

地点:卢嘉锡楼202报告厅

厦门大学谱学分析与仪器教育部重点实验室

厦门大学化学化工学院
2016年6月15日

报告摘要:

Hybrid microfluidic Lab-on-a-Chip and nanotechnologies for low-cost disease diagnosis

XiuJun (James) Li, Ph.D.

1:Department of Chemistry, 2: Border Biomedical Research Center (BBRC), 3: Biomedical Engineering (BME), 4:Material Science & Engineering (MASE), 5: Environmental Science & Engineering (ESE), University of Texas at El Paso, Texas, 79968


Infectious diseases and cancer are major “Killers” worldwide. The demands for rapid, accurate and low-cost early diagnosis of these diseases are challenging conventional diagnostic methods, especially in low-resource settings. Recently, fast growing microfluidic lab-on-a-chip and nanotechnologies have caused significant impact on modern disease diagnostics. Herein, I will highlight several paper/polymer hybrid microfluidic devices and nano-biosensing techniques that we recently developed for rapid disease diagnosis, especially for resource-poor settings. Difference chip substrates have different advantages as well as limitations. Paper/polymer hybrid microfluidic devices can draw more benefits from both substrates. Integrated graphene oxide nano-biosensors, on-chip DNA amplification and immunoassay, and nanoparticle-mediated photothermal immunosensing will also be discussed toward their applications in point-of-care infectious disease diagnosis and cancer biomarker detection.

附件:
报告摘要及报告人简介